Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rγnull mice engrafted with human erythrocytes

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 10, 2009, Pages 4533-4536

  Jiménez Díaz, María Belén ^a   Mulet, Teresa ^a   Viera, Sara ^a   Gómez, Vanessa ^a   Garuti, Helen ^a   Ibáñez, Javier ^a   Alvarez Doval, Angela ^a   Shultz, Leonard D ^b   Martínez, Antonio ^a   Gargallo Viola, Domingo ^a,c   Angulo Barturen, Iñigo ^a  

^a GLAXOSMITHKLINE   (Spain)

^b JACKSON LABORATORY   (United States)

^c Ferrer International SA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 PYRIDONE DERIVATIVE; ANTIMALARIAL AGENT; ARTESUNATE; BETA 2 MICROGLOBULIN; CHLOROQUINE; GSK 932121; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN 9; PYRIMETHAMINE; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENGRAFTMENT; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MALARIA FALCIPARUM; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SCID MOUSE;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DISEASE MODELS, ANIMAL; ERYTHROCYTES; HUMANS; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; KINETICS; MALARIA, FALCIPARUM; MICE; MICE, INBRED NOD; MICE, SCID; PYRIDONES; PYRIMETHAMINE;

EID: 70349313478     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00519-09     Document Type: Article

References (14)

1. Angulo-Barturen, I., M. B. Jiménez-Díaz, T. Mulet, J. Rullas, E. Herreros, S. Ferrer, E. Jiménez, A. Mendoza, J. Regadera, P. J. Rosenthal, I. Bathurst, D. L. Pompliano, F. Gómez de las Heras, and D. Gargallo-Viola. 2008. A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes. PLoS One 3:e2252.
2. Badell, E., V. Pasquetto, P. Druilhe, and N. Van Rooijen. 1995. A mouse model for human malaria erythrocytic stages. Parasitol. Today 11:235-237.
3. Bloland, P., P. Ringwald, and R. W. Snow. 2003. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. World Health Organization, Geneva, Switzerland. http://www.who.int/ malaria/docs/ProtocolWHO.pdf.
4. Christianson, S. W., D. L. Greiner, R. A. Hesselton, J. H. Leif, E. J. Wagar, I. B. Schweitzer, T. V. Rajan, B. Gott, D. C. Roopenian, and L. D. Shultz. 1997. Enhanced human CD4+ T cell engraftment in β2-microglobulin- deficient NOD-scid mice. J. Immunol. 158:3578-3586.
5. Coslédan, F., L. Fraisse, A. Pellet, F. O. Guillou, B. Mordmüller, P. G. Kremsner, A. Moreno, D. Mazier, J.-P. Maffrand, and B. Meunier. 2008. Selection of a trioxaquine as an antimalarial drug candidate. Proc. Natl. Acad. Sci. USA 105:17579-17584.
6. Greenwood, B. M., D. A. Fidock, D. E. Kyle, S. H. Kappe, P. L. Alonso, F. H. Collins, and P. E. Duffy. 2008. Malaria: progress, perils, and prospects for eradication. J. Clin. Investig. 118:1266-1276.
7. Jiménez-Díaz, M. B., T. Mulet, V. Gómez, S. Viera, A. Alvarez, H. Garuti, Y. Vázquez, A. Fernández, J. Ibáñez, M. Jiménez, D. Gargallo-Viola, and I. Angulo-Barturen. 2009. Quantitative measurement of Plasmodium-infected erythrocytes in murine models of malaria by flow cytometry using bidimensional assessment of SYTO-16 fluorescence. Cytometry A 75:225-235.
8. Moreno, A., E. Ferrer, S. Arahuetes, C. Eguiluz, N. V. Rooijen, and A. Benito. 2006. The course of infections and pathology in immunomodulated NOD/LtSz-SCID mice inoculated with Plasmodium falciparum laboratory lines and clinical isolates. Int. J. Parasitol. 36:361-369.
9. Newman, K. C., D. S. Korbel, J. C. Hafalla, and E. M. Riley. 2006. Cross-talk with myeloid accessory cells regulates human natural killer cell interferon-gamma responses to malaria. PLoS Pathog. 2:e118.
10. Pearson, T., D. L. Greiner, and L. D. Shultz. 2008. Humanized SCID mouse models for biomedical research. Curr. Top. Microbiol. Immunol. 324:25-51.
11. Peters, W., and B. L. Robinson. 1999. Malaria, p. 757-773. In O. Zak and M. A. Sande (ed.), Handbook of animal models of infection. Academic Press, New York, NY.
12. Shultz, L. D., F. Ishikawa, and D. L. Greiner. 2007. Humanized mice in translational biomedical research. Nat. Rev. Immunol. 7:118-130.
13. Shultz, L. D., B. L. Lyons, L. M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S. D. Gillies, M. King, J. Mangada, D. L. Greiner, and R. Handgretinger. 2005. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174:6477-6489.
14. Yeates, C. L., J. F. Batchelor, E. C. Capon, N. J. Cheesman, M. Fry, A. T. Hudson, M. Pudney, H. Trimming, J. Woolven, J. M. Bueno, J. Chicharro, E. Fernandez, J. M. Fiandor, D. Gargallo-Viola, F. Gomez de las Heras, E. Herreros, and M. L. Leon. 2008. Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials. J. Med. Chem. 51:2845-2852.